Prevention of microvascular complications in diabetic children and adolescents

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 427, 1999, Pages 35-38

  Verrotti, A ^a   Catino, M ^a   Di Ricco, L ^a   Casani, A ^a   Chiarelli, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Diabetes; Microvascular complications; Nephropathy; Retinopathy

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GANGLIOSIDE; VITAMIN;

ADOLESCENT; CHILD; CONFERENCE PAPER; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HUMAN; HYPERTENSION; JUVENILE DIABETES MELLITUS; MICROVASCULATURE; PRIORITY JOURNAL; VASCULAR DISEASE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; MALE; MICROCIRCULATION; PROGNOSIS; RISK FACTORS;

EID: 0032976526     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Belfiore F, Iannello S, Campione R, Volpicelli G, Caraffa F. Metabolic effects of hyperglycemia in various tissues. In: Belfiore F, Molinatti GM, Reaven GM, editors. Tissue-specific metabolic alterations in diabetes. Basle: Karger, 1990; 124-33
2. Chiarelli F, Verrotti A, Basciani F, di Ricco L, Sabatino G, Morgese G. Controversies on the prevention of diabetic nephropathy. J Pediatr Endocrinol Metab 1998; 11 Suppl 2: 365-8
3. Steffes MW, Basgen JM, Mauer SM. The evolution of diabetic nephropathy. In: Andreani D, Crepaldi G, Di Mario U, Pozza G, editors. Diabetic complications. Early diagnosis and treatment. New York: John Wiley and Sons Ltd, 1987; 223-31
4. Mortensen HB. Microalbuminuria in young patients with type 1 diabetes. In: Mogensen CE, editor. The kidney and hypertension in diabetes mellitus. Boston: Kluwer Academic Publishers, 1994; 285-95
5. Wang Ping H, Lau J, Chalmers TC. Meta-analysys of the effect of intensive therapy on nephropathy in type 1 diabetes mellitus. In: Mogensen CE, editor. The kidney and hypertension in diabetes mellitus. Boston: Kluwer Academic Publishers, 1994; 361-7
6. The EUCLID study group. Randomized placebo-controlled trial of Lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-92
7. Verrotti A, Lobefalo L, Chiarelli F. Lipids and lipoproteins in diabetic adolescents and young adults with retinopathy. Eye 1998; 11: 876-81
8. Danne T. Pathogenesis of diabetic angiopathy. In: Laron Z, Pinelli L, editors. Progress on childhood diabetes. Editoriale Bios, 1997; 93-101
9. Chiarelli F, di Ricco L, Verrotti A. Critical review on diabetic complications. In: Laron Z, Pinelli L, editors. Progress on childhood diabetes. Editoriale Bios 1997; 105-14
10. Aiello LM, Cavallerano J. Diabetic retinopathy. In: Bardin, editor. Current therapy in endocrinology and metabolism. St Louis: Mosby-Year Book Inc., 1997; 475-85
11. Greene DA, Lattimer SA, Sima AA. Tissue-specific metabolic alterations in the pathogenesis of diabetic peripheral neuropathy. In: Belfiore F, Molinatti GM, Reaven GM, editors. Tissue-specific metabolic alterations in diabetes. Basle: Karger, 1990; 83-96
12. Crepaldi G, Fedele D. Treatment of diabetic somatic neuropathies. In: Andreani D, Crepaldi G, Di Mario U, Pozza G, editors. Diabetic complications: early diagnosis and treatment. New York: John Wiley & Sons Ltd, 1987; 197-209
13. Becker DJ. Complications of insulin-dependent diabetes mellitus in childhood and adolescence. In: Lifshitz F, editor. Pediatric endocrinology. New York: Marcel Dekker Inc., 1997; 583-605